My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 122

    1.

    Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responses.

    Abernethy DR, Schwartz JB, Todd EL, Luchi R, Snow E.

    Ann Intern Med. 1986 Sep;105(3):329-36.PMID: 3740673 [PubMed - indexed for MEDLINE]Related articles

    2.

    Aging alters verapamil elimination and dynamics: single dose and steady-state responses.

    Schwartz JB.

    J Pharmacol Exp Ther. 1990 Oct;255(1):364-73.PMID: 2213568 [PubMed - indexed for MEDLINE]Related articles

    3.

    Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.

    Carosella L, Menichelli P, Alimenti M, Zuccala G, Gemma A, Cocchi A, Carbonin PU.

    Cardiovasc Drugs Ther. 1989 Jun;3(3):417-25.PMID: 2487538 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition.

    Abernethy DR, Gutkowska J, Winterbottom LM.

    Clin Pharmacol Ther. 1990 Jul;48(1):76-86.PMID: 2142447 [PubMed - indexed for MEDLINE]Related articles

    5.

    Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil.

    Schwartz JB, Troconiz IF, Verotta D, Liu S, Capili H.

    J Pharmacol Exp Ther. 1993 May;265(2):690-8.PMID: 8496816 [PubMed - indexed for MEDLINE]Related articles

    6.

    Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics.

    Schwartz JB, Capili H, Daugherty J.

    Clin Pharmacol Ther. 1994 May;55(5):509-17.PMID: 8181195 [PubMed - indexed for MEDLINE]Related articles

    7.

    Acute and chronic studies of diltiazem in elderly versus young hypertensive patients.

    Abernethy DR, Montamat SC.

    Am J Cardiol. 1987 Dec 14;60(17):116I-120I.PMID: 3687802 [PubMed - indexed for MEDLINE]Related articles

    8.

    Verapamil pharmacodynamics and disposition in obese hypertensive patients.

    Abernethy DR, Schwartz JB.

    J Cardiovasc Pharmacol. 1988 Feb;11(2):209-15.PMID: 2452316 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension.

    Abernethy DR, Schwartz JB, Plachetka JR, Todd EL, Egan JM.

    Am J Cardiol. 1987 Sep 15;60(8):697-702.PMID: 3661438 [PubMed - indexed for MEDLINE]Related articles

    10.

    Influence of autonomic blockade and aging on AV conduction and responses to verapamil in the beagle.

    Schwartz JB, Shen C, Garcia J, Capili H, Sniezek M.

    J Gerontol A Biol Sci Med Sci. 1995 Mar;50(2):M83-90.PMID: 7874594 [PubMed - indexed for MEDLINE]Related articles

    11.

    Baroreflex function in elderly hypertensives.

    McGarry K, Laher M, Fitzgerald D, Horgan J, O'Brien E, O'Malley K.

    Hypertension. 1983 Sep-Oct;5(5):763-6.PMID: 6618638 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension.

    Schwartz JB, Abernethy DR.

    Am J Cardiol. 1987 May 1;59(12):1111-7.PMID: 3578052 [PubMed - indexed for MEDLINE]Related articles

    13.

    Calcium antagonists in geriatric patients: diltiazem in elderly persons with hypertension.

    Montamat SC, Abernethy DR.

    Clin Pharmacol Ther. 1989 Jun;45(6):682-91.PMID: 2731407 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pharmacokinetics and pharmacodynamics of labetalol in elderly and young hypertensive patients following single and multiple doses.

    Rocci ML Jr, Vlasses PH, Cressman MD, Sirgo MA, Plachetka JR.

    Pharmacotherapy. 1990;10(2):92-9.PMID: 2349138 [PubMed - indexed for MEDLINE]Related articles

    15.

    Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.

    Robertson DR, Waller DG, Renwick AG, George CF.

    Br J Clin Pharmacol. 1988 Mar;25(3):297-305.PMID: 3358895 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Evaluation of the potential interaction between NaCl and prostaglandin inhibition in elderly individuals with isolated systolic hypertension.

    Alam S, Purdie DM, Johnson AG.

    J Hypertens. 1999 Aug;17(8):1195-202.PMID: 10466476 [PubMed - indexed for MEDLINE]Related articles

    17.

    Age-related changes in the pharmacodynamics of verapamil.

    Arnold TH, Vallner JJ, Tackett RL.

    Am Heart J. 1985 Nov;110(5):981-5.PMID: 4061274 [PubMed - indexed for MEDLINE]Related articles

    18.

    Improvement of the age-related impairment in left ventricular diastolic filling with verapamil in the normal human heart.

    Arrighi JA, Dilsizian V, Perrone-Filardi P, Diodati JG, Bacharach SL, Bonow RO.

    Circulation. 1994 Jul;90(1):213-9.PMID: 8025999 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.

    Al-Waili NS, Hasan NA.

    Eur J Med Res. 1999 May 26;4(5):193-8.PMID: 10336409 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of intravenous verapamil administration on left ventricular diastolic function in systemic hypertension.

    Betocchi S, Cuocolo A, Pace L, Chiariello M, Trimarco B, Alfano B, Ricciardelli B, Salvatore M, Condorelli M.

    Am J Cardiol. 1987 Mar 1;59(6):624-9.PMID: 3825903 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity